Next Article in Journal
Targeting Intracellular Calcium Signaling ([Ca2+]i) to Overcome Acquired Multidrug Resistance of Cancer Cells: A Mini-Overview
Next Article in Special Issue
Exosomal MicroRNAs in Breast Cancer towards Diagnostic and Therapeutic Applications
Previous Article in Journal
MTH1 as a Chemotherapeutic Target: The Elephant in the Room
Previous Article in Special Issue
Long Non-Coding RNAs: Key Regulators of Epithelial-Mesenchymal Transition, Tumour Drug Resistance and Cancer Stem Cells
Article Menu
Issue 5 (May) cover image

Export Article

Open AccessReview
Cancers 2017, 9(5), 49;

Diagnostic and Therapeutic Potential of MicroRNAs in Lung Cancer

Division of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo 135-8550, Japan
Academic Editors: Takahiro Ochiya and Ryou-u Takahashi
Received: 8 March 2017 / Revised: 13 April 2017 / Accepted: 8 May 2017 / Published: 9 May 2017
View Full-Text   |   Download PDF [237 KB, uploaded 9 May 2017]


Lung cancer is the leading cause of deaths resulting from cancer owing to late diagnosis and limited treatment intervention. MicroRNAs are short, non-coding RNA molecules that regulate gene expression post-transcriptionally by translational repression or target messenger RNA degradation. Accumulating evidence suggests various roles for microRNAs, including development and progression of lung cancers. Because microRNAs are degraded to a much lesser extent in formalin-fixed paraffin-embedded specimens and are present not only in tumor tissues but also in body fluids, there is an increased potential in microRNA analyses for cancer research. In this review, recent studies of microRNA are introduced and briefly summarized, with a focus on the association of microRNAs with histological subtypes, genetic driver alterations, therapeutically-targeted molecules, and carcinogens. The reported circulating microRNA signature for the early detection of lung cancer and the implications of microRNAs as the modulators of tumor immune response are also introduced. View Full-Text
Keywords: adenocarcinoma; asbestos; driver mutation; genetic alteration; histology; miRNA; molecular pathology; oncology; smoking adenocarcinoma; asbestos; driver mutation; genetic alteration; histology; miRNA; molecular pathology; oncology; smoking
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Inamura, K. Diagnostic and Therapeutic Potential of MicroRNAs in Lung Cancer. Cancers 2017, 9, 49.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top